{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:32:17Z","timestamp":1793172737026,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-026-01098-2","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:26:57Z","timestamp":1773455217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Olmesartan-associated enteropathy presenting with metabolic acidosis and acute kidney injury requiring hemodialysis: a rechallenge-confirmed case"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7952-4175","authenticated-orcid":false,"given":"Takuya","family":"Sugiura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikazu","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yokoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"issue":"8","key":"1098_CR1","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.mayocp.2012.06.003","volume":"87","author":"A Rubio-Tapia","year":"2012","unstructured":"Rubio-Tapia A, Herman ML, Ludvigsson JF, Kelly DG, Mangan TF, Wu TT, et al. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc. 2012;87(8):732\u20138.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"1098_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.rgmxen.2019.10.005","volume":"85","author":"R Alonso-Beato","year":"2020","unstructured":"Alonso-Beato R, Gonz\u00e1lez-P\u00e9rez JA, Demelo-Rodr\u00edguez P. Severe olmesartan-induced sprue-like enteropathy with good corticosteroid treatment response. Rev Gastroenterol Mex. 2020;85(2):220\u20132. https:\/\/doi.org\/10.1016\/j.rgmxen.2019.10.005.","journal-title":"Rev Gastroenterol Mex"},{"issue":"1","key":"1098_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/apt.12780","volume":"40","author":"G Ianiro","year":"2014","unstructured":"Ianiro G, Bibb\u00f2 S, Montalto M, Ricci R, Gasbarrini A, Cammarota G. Systematic review: sprue-like enteropathy associated with olmesartan. Aliment Pharmacol Ther. 2014;40(1):16\u201323.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"1098_CR4","first-page":"346","volume":"27","author":"TH Tran","year":"2014","unstructured":"Tran TH, Silva-Alvarenga M, Nguyen H, Moghadamfalahi M, Levy N. Olmesartan and drug-induced enteropathy. Proc (Bayl Univ Med Cent). 2014;27(4):346\u20138.","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"10","key":"1098_CR5","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.5858\/arpa.2015-0204-RA","volume":"139","author":"EY Choi","year":"2015","unstructured":"Choi EY, McKenna BJ. Olmesartan-associated enteropathy: a review of clinical and histologic findings. Arch Pathol Lab Med. 2015;139(10):1242\u20137.","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"1098_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000370205","volume":"33","author":"EV Marietta","year":"2015","unstructured":"Marietta EV, Cartee AK, Rishi A, Murray JA, et al. Drug-induced enteropathy. Dig Dis. 2015;33(2):215\u201320.","journal-title":"Dig Dis"},{"key":"1098_CR7","volume":"6","author":"M Teixeira","year":"2019","unstructured":"Teixeira M, Macedo S, Martins A, Batista T, Novais A, Costa M, et al. Olmesartan-associated enteropathy: an unexpected cause of chronic diarrhoea. Eur J Case Rep Intern Med. 2019;6:001093.","journal-title":"Eur J Case Rep Intern Med"},{"issue":"2","key":"1098_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jpge.2016.02.005","volume":"23","author":"IA Hujoel","year":"2016","unstructured":"Hujoel IA, Rubio-Tapia A. Sprue-like enteropathy associated with olmesartan: a new kid on the enteropathy block. GE Port J Gastroenterol. 2016;23(2):61\u20135.","journal-title":"GE Port J Gastroenterol"},{"issue":"7","key":"1098_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/diseases13070223","volume":"13","author":"L Bekkai","year":"2025","unstructured":"Bekkai L, Ibn Majah A, Verset L, Jacobs L, Danneel C, Elkilic O, et al. Atypical rapid onset of olmesartan-induced enteropathy with recurrence after rechallenging. Diseases. 2025;13(7):223. https:\/\/doi.org\/10.3390\/diseases13070223.","journal-title":"Diseases"},{"issue":"2","key":"1098_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jpge.2015.12.003","volume":"23","author":"L Carneiro","year":"2016","unstructured":"Carneiro L, Moreira A, Pereira A, Andrade C, Soares J, Silva A. Olmesartan-induced sprue-like enteropathy. GE Port J Gastroenterol. 2016;23(2):101\u20135. https:\/\/doi.org\/10.1016\/j.jpge.2015.12.003.","journal-title":"GE Port J Gastroenterol"},{"issue":"8","key":"1098_CR11","doi-asserted-by":"publisher","DOI":"10.12890\/2020_001614","volume":"7","author":"ARF Matos","year":"2020","unstructured":"Matos ARF, Coelho E, Caridade S. Olmesartan-induced enteropathy: a case of recurrent diarrhoea. Eur J Case Rep Intern Med. 2020;7(8):001614. https:\/\/doi.org\/10.12890\/2020_001614.","journal-title":"Eur J Case Rep Intern Med"},{"issue":"2","key":"1098_CR12","doi-asserted-by":"publisher","DOI":"10.51894\/001c.6383","volume":"2","author":"R Handa","year":"2017","unstructured":"Handa R, Rahman A, Kak V. Rare case of olmesartan-induced enteropathy. Spartan Med Res J. 2017;2(2):6383. https:\/\/doi.org\/10.51894\/001c.6383.","journal-title":"Spartan Med Res J"},{"key":"1098_CR13","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/apt.13413","volume":"42","author":"EV Marietta","year":"2015","unstructured":"Marietta EV, Nadeau AM, Cartee AK, Singh I, Rishi A, Choung RS, et al. Immunopathogenesis of olmesartan-associated enteropathy. Aliment Pharmacol Ther. 2015;42:1303\u201314. https:\/\/doi.org\/10.1111\/apt.13413.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"1098_CR14","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1136\/gut.2004.059998","volume":"54","author":"RP Anderson","year":"2005","unstructured":"Anderson RP, van Heel DA, Tye-Din JA, Barnardo M, Salio M, Jewell DP, et al. T cells in peripheral blood after gluten challenge in coeliac disease. Gut. 2005;54(9):1217\u201323. https:\/\/doi.org\/10.1136\/gut.2004.059998.","journal-title":"Gut"},{"issue":"3","key":"1098_CR15","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.3390\/ijms24032075","volume":"24","author":"T Tamai","year":"2023","unstructured":"Tamai T, Ihara K. Celiac disease genetics, pathogenesis, and standard therapy for Japanese patients. Int J Mol Sci. 2023;24(3):2075. https:\/\/doi.org\/10.3390\/ijms24032075.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1098_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-070985","volume":"13","author":"E Eworuke","year":"2023","unstructured":"Eworuke E, et al. Valsartan, losartan and irbesartan use in the USA, UK, Canada and Denmark: a cross-sectional analysis. BMJ Open. 2023;13(4):e070985.","journal-title":"BMJ Open"},{"issue":"6","key":"1098_CR17","first-page":"825","volume":"110","author":"ML Herman","year":"2015","unstructured":"Herman ML, Rubio-Tapia A, Wu TT, Murray JA. A case of severe sprue-like enteropathy associated with valsartan. Am J Gastroenterol. 2015;110(6):825\u20137.","journal-title":"Am J Gastroenterol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-026-01098-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-026-01098-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-026-01098-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T15:01:59Z","timestamp":1773500519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-026-01098-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1098"],"URL":"https:\/\/doi.org\/10.1007\/s13730-026-01098-2","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Shoichi Maruyama has received honoraria and research support from several pharmaceutical companies, as disclosed in the ICMJE COI form. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"60"}}